Quantum BioPharma Ltd. (QNTM)

NASDAQ: QNTM · Real-Time Price · USD

21.72

+0.60 (2.84%)

At close: Jun 27, 2025, 4:00 PM

21.70

-0.02 (-0.09%)

After-hours: Jun 27, 2025, 7:55 PM EDT

Quantum BioPharma Employees

Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.

Employees

17

Change (1Y)

7

Growth (1Y)

70.00%

Revenue / Employee

n/a

Profits / Employee

-$1,228,004

Market Cap

91.24M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2022	17	7	70.00%
Dec 31, 2021	10	1	11.11%
Dec 31, 2020	9	-9	-50.00%
Dec 31, 2019	18	-1	-5.26%
Dec 31, 2018	19	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

QNTM News

1 day ago - Quantum BioPharma Announces Private Placement - GlobeNewsWire
2 days ago - Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering - GlobeNewsWire
10 days ago - Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress - Newsfile Corp
11 days ago - Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital - GlobeNewsWire
15 days ago - Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds - GlobeNewsWire
25 days ago - Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewsWire
26 days ago - iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients - GlobeNewsWire
4 weeks ago - Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - GlobeNewsWire